CTOs on the Move

Bisco Inc

www.bisco.com

 
Bisco Inc is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bisco.com
  • 1100 W Irving Park Rd
    Schaumburg, IL USA 60193
  • Phone: 847.534.6000

Executives

Name Title Contact Details

Similar Companies

AMN Healthcare

AMN Healthcare is the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare`s workforce solutions - including managed services programs and recruitment process outsourcing - enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the largest network of quality clinicians and physicians through its innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, government facilities, community health centers and clinics, physician practice groups and many other healthcare settings.

Westside Natural Health Clinic

Westside Natural Health Clinic is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Haven Health

Haven Health Group is a group of individual long term care facilities based throughout Arizona that provide skilled nursing, rehabilitation, respite, hospice, physical, occupational, and speech therapy, and long term care services.

Infinata

Infinata is a Norwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.